Therapeutic monoclonal antibodies for respiratory diseases: Current challenges and perspectives, March 31 – April 1, 2016, Tours, France

Therapeutic monoclonal antibodies for respiratory diseases: Current challenges and perspectives, March 31 – April 1, 2016, Tours, France

Monoclonal antibody (mAb) therapeutics have tremendous potential to benefit patients with lung diseases, for which there remains substantial unmet medical need. To capture the current state of mAb research and development in the area of respiratory diseases, the Research Center of Respiratory Diseas...

Full description

Bibliographic Details
Main Authors: Desoubeaux, Guillaume, Reichert, Janice M., Sleeman, Matthew, Reckamp, Karen L., Ryffel, Bernhard, Adamczewski, Jörg P., Sweeney, Theresa D., Vanbever, Rita, Diot, Patrice, Owen, Caroline A., Page, Clive, Lerondel, Stéphanie, Le Pape, Alain, Heuze-Vourc'h, Nathalie
Format: Online
Language:English
Published: Taylor & Francis 2016
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4968091/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4968091/

Similar Items